We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$456M
AUM Growth
+$2.09M
Cap. Flow
-$9.77M
Cap. Flow %
-2.14%
Top 10 Hldgs %
14.03%
Holding
362
New
46
Increased
61
Reduced
100
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.2M
2
IVZ icon
Invesco
IVZ
+$3.16M
3
DELL icon
Dell
DELL
+$2.9M
4
PFE icon
Pfizer
PFE
+$2.83M
5
JNPR
Juniper Networks
JNPR
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 15.25%
2 Consumer Discretionary 14.74%
3 Materials 12.22%
4 Technology 12.17%
5 Consumer Staples 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXF icon
251
Invesco CurrencyShares Swiss Franc Trust
FXF
$398M
$494K 0.11%
5,000
NS
252
DELISTED
NuStar Energy L.P.
NS
$492K 0.11%
31,000
LSTR icon
253
Landstar System
LSTR
$6.14B
$465K 0.1%
2,600
-2,600
-50% -$446K
TXG icon
254
10x Genomics
TXG
$6.14B
$462K 0.1%
3,100
RBNC
255
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$461K 0.1%
13,000
-5,000
-28% -$170K
CPRX
256
DELISTED
Catalyst Pharmaceutical
CPRX
$460K 0.1%
68,000
-56,000
-45% -$368K
MATW icon
257
Matthews International
MATW
$733M
$455K 0.1%
12,400
-3,100
-20% -$112K
PBF icon
258
PBF Energy
PBF
$7.4B
$454K 0.1%
35,000
FITB
259
Fifth Third Bancorp
FITB
$51.7B
$453K 0.1%
10,400
-5,100
-33% -$223K
AVA icon
260
Avista
AVA
$3.26B
$425K 0.09%
10,000
FE icon
261
FirstEnergy
FE
$27.5B
$416K 0.09%
10,000
RIGL icon
262
Rigel Pharmaceuticals
RIGL
$758M
$413K 0.09%
+15,600
New +$471K
UHS icon
263
Universal Health Services
UHS
$10.4B
$402K 0.09%
3,100
TPIC
264
DELISTED
TPI Composites
TPIC
$389K 0.09%
+26,000
New +$638K
SUNW
265
DELISTED
Sunworks, Inc.
SUNW
$381K 0.08%
124,000
BKD icon
266
Brookdale Senior Living
BKD
$3.42B
$372K 0.08%
72,000
BVN icon
267
Compañía de Minas Buenaventura
BVN
$8.68B
$366K 0.08%
50,000
JBL icon
268
Jabil
JBL
$36.1B
$366K 0.08%
5,200
-10,300
-66% -$651K
ALKS icon
269
Alkermes
ALKS
$8.2B
$361K 0.08%
15,500
STRA icon
270
Strategic Education
STRA
$1.88B
$359K 0.08%
6,200
BKH icon
271
Black Hills Corp
BKH
$5.69B
$353K 0.08%
5,000
NATR icon
272
Nature's Sunshine
NATR
$295M
$344K 0.08%
18,600
NG icon
273
NovaGold Resources
NG
$3.22B
$343K 0.08%
50,000
WMK icon
274
Weis Markets
WMK
$1.87B
$343K 0.08%
5,200
-4,000
-43% -$243K
SO icon
275
Southern Company
SO
$107B
$342K 0.08%
5,000

Similar funds

Hussman Strategic Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Hussman Strategic Advisors held 362 positions worth $456M, up 0.46% from $454M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors's Q4 2021 filing shows 46 new, 61 increased, 100 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M. The largest sale was Meredith Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Hussman Strategic Advisors's largest Q4 2021 buy was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M.
  • Hussman Strategic Advisors added most to Newmont in Q4 2021, an estimated $2.27M increase.
  • Hussman Strategic Advisors's biggest Q4 2021 reduction was Clearfield, cutting an estimated $2.59M.
  • Hussman Strategic Advisors fully exited Meredith Corporation in Q4 2021, selling an estimated $2.9M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $456M portfolio in Q4 2021.
  • Hussman Strategic Advisors opened 46 new positions and closed 43 in Q4 2021.
  • Hussman Strategic Advisors's portfolio value rose 0.46% quarter-over-quarter to $456M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.